| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
538,409 |
528,409 |
$34.95M |
| S9083 |
Global fee urgent care centers |
171,131 |
168,534 |
$19.23M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
187,396 |
182,942 |
$17.92M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
145,209 |
144,725 |
$11.66M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
38,635 |
38,224 |
$5.17M |
| 99050 |
|
345,078 |
342,416 |
$3.90M |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
126,405 |
119,926 |
$2.82M |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
23,149 |
21,953 |
$1.51M |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
54,184 |
52,862 |
$1.33M |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
22,867 |
22,483 |
$1.07M |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
17,313 |
17,291 |
$1.02M |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
91,497 |
47,231 |
$982K |
| 99215 |
Prolong outpt/office vis |
5,054 |
5,010 |
$893K |
| 99051 |
|
124,737 |
120,732 |
$884K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
36,714 |
36,539 |
$780K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
115,754 |
114,492 |
$533K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
23,130 |
21,940 |
$502K |
| 99205 |
Prolong outpt/office vis |
1,735 |
1,725 |
$344K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
5,720 |
5,630 |
$216K |
| 71046 |
Radiologic examination, chest; 2 views |
6,566 |
6,423 |
$118K |
| 81025 |
|
19,564 |
19,001 |
$68K |
| 81003 |
|
49,562 |
48,466 |
$60K |
| 73610 |
|
1,945 |
1,923 |
$46K |
| 73630 |
|
2,036 |
2,014 |
$45K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,416 |
3,239 |
$31K |
| S9088 |
Services provided in an urgent care center (list in addition to code for service) |
1,035 |
956 |
$30K |
| 12001 |
|
519 |
517 |
$29K |
| 87807 |
|
2,972 |
2,961 |
$28K |
| 73130 |
|
1,125 |
1,113 |
$26K |
| 73110 |
|
904 |
895 |
$25K |
| 29540 |
|
1,257 |
1,250 |
$24K |
| E0114 |
Crutches underarm, other than wood, adjustable or fixed, pair, with pads, tips and handgrips |
609 |
608 |
$22K |
| 90715 |
|
771 |
766 |
$22K |
| 93000 |
|
1,712 |
1,709 |
$17K |
| 73140 |
|
588 |
585 |
$14K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
886 |
880 |
$10K |
| 73562 |
|
383 |
381 |
$10K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,063 |
1,030 |
$9K |
| 73030 |
|
361 |
358 |
$8K |
| L3580 |
Orthopedic shoe addition, convert instep to velcro closure |
129 |
129 |
$6K |
| 86308 |
|
1,528 |
1,515 |
$6K |
| 10060 |
|
82 |
82 |
$4K |
| 29530 |
|
195 |
194 |
$4K |
| L3807 |
Wrist hand finger orthosis, without joint(s), prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise |
24 |
24 |
$4K |
| 71101 |
|
145 |
139 |
$4K |
| 73080 |
|
100 |
100 |
$2K |
| 82962 |
|
630 |
624 |
$1K |
| 36415 |
Collection of venous blood by venipuncture |
2,401 |
2,392 |
$952.20 |
| 29125 |
|
29 |
29 |
$909.61 |
| 29260 |
|
30 |
30 |
$620.25 |
| 69209 |
|
84 |
83 |
$589.93 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
785 |
761 |
$573.24 |
| 0002A |
|
18 |
18 |
$536.40 |
| 72100 |
|
25 |
24 |
$488.54 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
757 |
742 |
$422.42 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
660 |
651 |
$411.83 |
| 0001A |
|
13 |
13 |
$405.69 |
| S8451 |
Splint, prefabricated, wrist or ankle |
66 |
66 |
$311.69 |
| 71045 |
Radiologic examination, chest; single view |
32 |
32 |
$298.20 |
| 73560 |
|
12 |
12 |
$167.15 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
235 |
234 |
$149.28 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
462 |
458 |
$57.86 |
| Q4049 |
Finger splint, static |
13 |
13 |
$11.05 |
| A6448 |
Light compression bandage, elastic, knitted/woven, width less than three inches, per yard |
459 |
459 |
$1.16 |
| A4565 |
Slings |
13 |
13 |
$0.00 |
| A6449 |
Light compression bandage, elastic, knitted/woven, width greater than or equal to three inches and less than five inches, per yard |
108 |
108 |
$0.00 |